APP and Alzheimer disease: Using in vivo models of the disease, earlier evidence showed that the administration of S14G-HN, a more potent humanin derivative, ameliorated the cognitive performance of Aβ-injected [207] and 3xTg-AD [208] mice and reduced Aβ accumulation and neuroinflammation in the brains of middle-aged APP/PS1 mice [209].